Drug-drug interactions in hepatitis C virus treatment: Do they really matter?
Author:
Affiliation:
1. Division of Gastroenterology and Hepatology; Stanford University School of Medicine; Stanford CA
Publisher
Wiley
Subject
Hepatology
Reference15 articles.
1. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study;Kondili;PLoS One,2017
2. Telaprevir (Incivek) and boceprevir (Victrelis) for chronic hepatitis C;Med Lett Drugs Ther,2011
3. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus;Garg;Hepatology,2011
4. A clinician's guide to drug-drug interactions with direct-acting antiviral agents for the treatment of hepatitis C viral infection;Dick;Hepatology,2016
5. Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir;Menon;J Hepatol,2015
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation;Drug Metabolism and Disposition;2024-01-24
2. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA);Therapeutics and Clinical Risk Management;2023-01
3. Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system;Microbial Pathogenesis;2022-07
4. Liver Transplantation Using Hepatitis C Virus–Viremic Donors Into Hepatitis C Virus–Aviremic Recipients as Standard of Care;Liver Transplantation;2021-04
5. Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium : an observational study;Acta Gastro Enterologica Belgica;2021-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3